Prescription Abuse and Diversion by Secondary Students

处方药的非医疗使用和转移是青少年中日益严重的问题。2002年，青少年非医疗处方滥用的终生患病率总体报告为13.7%，其中11.2%报告了止痛药的非医疗使用。尽管目前青少年滥用处方药的流行率相对较高，但这种形式的药物滥用在研究文献中得到的关注相对较少。这一R 03应用程序的主要目的，处方药滥用和转移的中学生是为了提高我们的理解，非医疗使用和处方药的转移，在一个横断面样本的7日至12日年级居住在一个学区在大都市 底特律四类处方药（例如兴奋剂，止痛药，镇静剂和睡眠）将是本次调查的重点，因为目前的研究表明这些药物有滥用的可能性，青少年经常被处方这些药物用于合法的医疗条件，增加了这些药物被转移的可能性。为了达到研究目的，将描述报告非医疗使用或转移的学生的特征，并描述他们的药物使用行为;还将描述学生亚组（性别，种族等）。处方药的非医疗使用和转移的相关性将检查与以前的处方，物质使用，和动机使用处方非医疗。我们的长期目标是制定和评估一项具体的预防计划， 使用R 01机制的处方滥用和转移。

The nonmedical use and diversion of prescription drugs is an increasing problem among adolescents. In 2002, lifetime prevalence rates for adolescents' nonmedical prescription abuse was reported at 13.7% overall, with 11.2% reporting the nonmedical use of pain relievers. Despite the current and relatively high prevalence of prescription abuse by adolescents, this form of drug abuse receives relatively scant attention in the research literature. The primary purpose of this R03 application, Prescription Abuse and Diversion by Secondary Students is to advance our understanding of the nonmedical use and diversion of prescription drugs in a cross-sectional sample of 7th through 12th graders residing in one school district in metropolitan Detroit. Four categories of prescription drugs (e.g. stimulant, pain, sedative and sleep) will be the focus of this inquiry because current research suggests these medications have abuse potential and adolescents often are prescribed these drugs for legitimate medical conditions, increasing the likelihood that these medications will be diverted. To meet the study aims, students who report nonmedical use or diversion will be characterized and their drug use behaviors described; subgroups of students (gender, racial, etc) will be described as well. The correlates of the nonmedical use and diversion of prescription drugs will be examined in relation to previous prescriptions, substance use, and motivations to use prescriptions nonmedically. Our long term objective is to develop and evaluate a specific prevention program to reduce prescription abuse and diversion using an R01 mechanism.